Maruho planning Japanese submission for pruritus therapy

Maruho said it will submit a regulatory application in Japan for nemolizumab after reporting that the compound

Read the full 170 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE